Fainting Clinical Trials

Find Fainting Clinical Trials Near You

Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Heart rhythm disorders are common and significantly impact the lives of those affected and their families. The main problems can be categorized as: a) atrial fibrillation or AF and atrial flutter, b) supra-ventricular tachycardia or SVT, c) excessively slow heart beats (i.e., bradycardia or pauses) and d) ventricular arrhythmias. These problems can be difficult to detect with currently available monitoring options as they are all worn for shorter terms or are an invasive implantable option. The HeartWatch is a longer term monitoring system that is worn on the upper arm, allows users to create a tag and pairs with an app on a smartphone allowing for correlation of symptoms.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 22
Healthy Volunteers: f
View:

• At least 22 years of age at time of consent

• Clinically indicated for a Holter monitor test

• Able to wear the HeartWatch on the left bicep for the study duration

• Able to follow the protocol

• No functional implantable pacemaker or defibrillator

• Left bicep circumference \>/= 22 cm and \</= 45 cm

• Provision of written-informed consent

Locations
Other Locations
Canada
Foothills Medical Centre University of Calgary
RECRUITING
Calgary
Contact Information
Primary
Karen Cowan
kcowan@ucalgary.ca
4035600225
Backup
Owen Gillett
owen.gillett@helpwear.ca
647-994-4077
Time Frame
Start Date: 2024-02-20
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 300
Treatments
Other: Active device engagement
All subjects will wear either the Holter monitor and the HeartWatch.
Sponsors
Leads: HelpWear Inc.

This content was sourced from clinicaltrials.gov